Harris CL - Search Results

1

A bispecific monoclonal antibody directed against both the membrane-bound complement regulator CD55 and the renal tumor-associated antigen G250 enhances C3 deposition and tumor cell lysis by complement.

Blok VT, Daha MR, Tijsma O, Harris CL, Morgan BP, Fleuren GJ, Gorter A. Blok VT, et al. Among authors: harris cl. J Immunol. 1998 Apr 1;160(7):3437-43. J Immunol. 1998. PMID: 9531304

2

Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell line.

Harris CL, Morgan BP. Harris CL, et al. Immunology. 1995 Oct;86(2):311-8. Immunology. 1995. PMID: 7490134 Free PMC article.

3

Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59.

Harris CL, Kan KS, Stevenson GT, Morgan BP. Harris CL, et al. Clin Exp Immunol. 1997 Feb;107(2):364-71. doi: 10.1111/j.1365-2249.1997.265-ce1156.x. Clin Exp Immunol. 1997. PMID: 9030877 Free PMC article.

4

Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Harris CL, Spiller OB, Morgan BP. Harris CL, et al. Immunology. 2000 Aug;100(4):462-70. doi: 10.1046/j.1365-2567.2000.00066.x. Immunology. 2000. PMID: 10929073 Free PMC article.

5

Pigs express multiple forms of decay-accelerating factor (CD55), all of which contain only three short consensus repeats.

Pérez de la Lastra JM, Harris CL, Hinchliffe SJ, Holt DS, Rushmere NK, Morgan BP. Pérez de la Lastra JM, et al. Among authors: harris cl. J Immunol. 2000 Sep 1;165(5):2563-73. doi: 10.4049/jimmunol.165.5.2563. J Immunol. 2000. PMID: 10946283

6

Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cells.

Spiller OB, Harris CL, Morgan BP. Spiller OB, et al. Among authors: harris cl. J Immunol Methods. 1999 Apr 22;224(1-2):51-60. doi: 10.1016/s0022-1759(99)00008-3. J Immunol Methods. 1999. PMID: 10357206

7

Characterization of glycosylphosphatidylinositol-anchored decay accelerating factor (GPI-DAF) and transmembrane DAF gene expression in wild-type and GPI-DAF gene knockout mice using polyclonal and monoclonal antibodies with dual or single specificity.

Miwa T, Sun X, Ohta R, Okada N, Harris CL, Morgan BP, Song WC. Miwa T, et al. Among authors: harris cl. Immunology. 2001 Oct;104(2):207-14. doi: 10.1046/j.1365-2567.2001.01280.x. Immunology. 2001. PMID: 11683961 Free PMC article.

8

Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivo.

Harris CL, Williams AS, Linton SM, Morgan BP. Harris CL, et al. Clin Exp Immunol. 2002 Aug;129(2):198-207. doi: 10.1046/j.1365-2249.2002.01924.x. Clin Exp Immunol. 2002. PMID: 12165074 Free PMC article.

9

The membrane attack pathway of complement drives pathology in passively induced experimental autoimmune myasthenia gravis in mice.

Morgan BP, Chamberlain-Banoub J, Neal JW, Song W, Mizuno M, Harris CL. Morgan BP, et al. Among authors: harris cl. Clin Exp Immunol. 2006 Nov;146(2):294-302. doi: 10.1111/j.1365-2249.2006.03205.x. Clin Exp Immunol. 2006. PMID: 17034582 Free PMC article.

10

Molecular and functional analysis of mouse decay accelerating factor (CD55).

Harris CL, Rushmere NK, Morgan BP. Harris CL, et al. Biochem J. 1999 Aug 1;341 ( Pt 3)(Pt 3):821-9. Biochem J. 1999. PMID: 10417349 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters